Pharmaceutically important pre- and posttranslational modifications on human serum albumin.

Abstract excerpt

Recombinant technology allows engineering and production of proteins with desirable properties. Human serum albumin has been developed with recombinant technology, and thus plays an increasing role as a drug carrier in the clinical setting. Genetic variations usually occur on the surface of the protein, and do not impose significant effects on the conformation of albumin. However, binding of fatty acids by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Variation
• Share to Models, Molecular
• Share to Protein Processing, Post-Translational